MYNX M5 Trademark

Trademark Overview

On Tuesday, June 23, 2009, a trademark application was filed for MYNX M5 with the United States Patent and Trademark Office. The USPTO has given the MYNX M5 trademark a serial number of 77766680. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, October 6, 2017. This trademark is owned by AccessClosure, Inc.. The MYNX M5 trademark is filed in the Medical Instrument Products category with the following description:

Vascular hemostasis devices, namely, balloon catheters with integral shuttle and sealant for sealing arterial access sites
mynx m5

General Information

Serial Number77766680
Word MarkMYNX M5
Filing DateTuesday, June 23, 2009
Status710 - CANCELLED - SECTION 8
Status DateFriday, October 6, 2017
Registration Number3924512
Registration DateTuesday, March 1, 2011
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 14, 2010

Trademark Statements

Goods and ServicesVascular hemostasis devices, namely, balloon catheters with integral shuttle and sealant for sealing arterial access sites
Pseudo MarkMYNX M FIVE

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, October 6, 2017
Primary Code010
First Use Anywhere DateMonday, June 1, 2009
First Use In Commerce DateMonday, June 1, 2009

Trademark Owner History

Party NameAccessClosure, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMountain View, CA 94043
Party NameAccessClosure, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMountain View, CA 94043
Party NameAccessClosure, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMountain View, CA 94043

Trademark Events

Event DateEvent Description
Friday, October 6, 2017CANCELLED SEC. 8 (6-YR)
Tuesday, March 1, 2016COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, January 26, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 25, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, June 25, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 21, 2012ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, February 15, 2012ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, March 1, 2011REGISTERED-PRINCIPAL REGISTER
Tuesday, December 14, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 14, 2010PUBLISHED FOR OPPOSITION
Monday, November 8, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, November 8, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 14, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 13, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 13, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 23, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 23, 2010NON-FINAL ACTION E-MAILED
Monday, August 23, 2010NON-FINAL ACTION WRITTEN
Friday, July 23, 2010LIE CHECKED SUSP - TO ATTY FOR ACTION
Tuesday, January 19, 2010NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, January 19, 2010LETTER OF SUSPENSION E-MAILED
Tuesday, January 19, 2010SUSPENSION LETTER WRITTEN
Friday, December 18, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 18, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 18, 2009ASSIGNED TO LIE
Thursday, December 10, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 24, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 24, 2009NON-FINAL ACTION E-MAILED
Thursday, September 24, 2009NON-FINAL ACTION WRITTEN
Monday, September 21, 2009ASSIGNED TO EXAMINER
Saturday, June 27, 2009NOTICE OF PSEUDO MARK MAILED
Friday, June 26, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, June 26, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

mynx sealing sealant arterial access sites shuttle integral devices hemostasis namely